Article Information
History
- November 4, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Judith Arres1,*,
- Santosh Elavalli1,*,
- Shalini Behl1,
- Daniel Matias Sanchez1,
- Ayesha Al Ali1,
- Abdelrahman Ahmed Yehia Abdelaziz Saad1,
- Azza Attia1,
- Cyla Minas1,
- Sharika Pariyachery1,
- Shariq Ahmed1,
- Fatmah Aldhuhoori1,
- Nitu Thulasidharan1,
- Gurunath Katagi1,
- Omar Soliman1,
- Shilp Purohit1,
- Vinay Kusuma1,
- Thyago Cardoso1,
- Luis F Paulin2,
- Philippe Sanio2,
- Joseph Mafofo1,
- Haiguo Wu1,
- Val Zvereff1,
- Albarah El-Khani1,
- Fahed Al Marzooqi1,
- Tiago R Magalhães1,
- Fritz Sedlazeck2,3,4 and
- Javier Quilez1,#
- 1M42
- 2Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA
- 3Department of Molecular and Human Genetics, Baylor College of Medicine, TX, USA
- 4Department of Computer Science, Rice University, 6100 Main Street, Houston, TX, USA
- ↵#Corresponding author; jquilez{at}m42.ae
Posted November 04, 2024.
Assessing the readiness of Oxford Nanopore sequencing for clinical genomics applications
